CROI 2020 - CROI 2020

WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES

"ADVANCES IN MOLECULAR VIROLOGY" by Wesley I. Sundquist of University of Utah, Salt Lake City, UT, USA

WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES

"ADVANCES IN HIV IMMUNOLOGY AND VACCINES" by Richard A. Koup of National Institutes of Health, Bethesda, MD, USA

WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES

"ISSUES IN MATERNAL, INFANT, AND CHILD HEALTH" by Hermione Lyall of Imperial College Healthcare NHS Trust, London, United Kingdom

WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES

"ADVANCES IN HIV PREVENTION" by Susan P. Buchbinder of San Francisco Department of Public Health, San Francisco, CA, USA

WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES

"ADVANCES IN HIV CURE" by Nicolas Chomont of Université de Montréal, Montreal, QC, Canada

WORKSHOP: FRONTIERS IN LABORATORY SCIENCE

"SHAPING VACCINES WITH DNA ORIGAMI" by Mark Bathe of Massachusetts Institute of Technology, Cambridge, MA, USA

WORKSHOP: FRONTIERS IN LABORATORY SCIENCE

"CONCEPTS IN RESERVOIR MEASUREMENTS" by Janet M. Siliciano of The Johns Hopkins University, Baltimore, MD, USA

WORKSHOP: FRONTIERS IN LABORATORY SCIENCE

"CHARTING GENOME-WIDE INTEGRATION" by Mary F Kearney of National Cancer Institute, Frederick, MD, USA

WORKSHOP: FRONTIERS IN LABORATORY SCIENCE

"SINGLE-CELL EPIGENETICS: COLORING IMMUNE CELLS WITH A RICH PALETTE OF HISTONE MARKS" by Alex J Kuo of Stanford University, Stanford, CA, USA

WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS

"PUTTING ANALYSIS INTO ANALYTICAL TREATMENT INTERRUPTIONS" by Lu (Summer) Zheng of Harvard T. H. Chan School of Public Health, Boston, MA, USA

WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS

"ADVANCING FROM PHASE II TO PHASE III: NAVIGATING THE LAND OF EXPECTATIONS" by Patrick PJ Phillips of University of California San Francisco, San Francisco, CA, USA

WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS

"NONINFERIORITY COMPLEX" by Jeffrey Scott Murray of Food and Drug Administration, Silver Spring, MD, USA

WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS

"INCLUSION OF DIVERSE POPULATIONS IN TRIALS" by Mark Harrington of Treatment Action Group, New York, NY, USA

WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP: WHAT'S EATING YOUR LIVER?

"WHEN AT THIRD YOU DON'T SUCCEED" by David L. Wyles of Denver Health and Hospital Authority, Denver, CO, USA

WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP: WHAT'S EATING YOUR LIVER?

"'A' CASE TO REMEMBER: HEPATITIS A - MANAGING AN OLD VIRUS IN NEW POPULATIONS AT RISK" by Darcy Wooten of University of California San Diego, San Diego, CA, USA

WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP: WHAT'S EATING YOUR LIVER?

"HEPATOCELLULAR CARCINOMA" by Susanna Naggie of Duke University, Durham, NC, USA

OPENING SESSION

"OPENING SESSION HOST" by Sharon L. Hillier of University of Pittsburgh, Pittsburgh, PA, USA

OPENING SESSION

"THE ANCIENT AND MODERN ORIGINS OF HIV" by Michael Emerman of Fred Hutchinson Cancer Research Center, Seattle, WA, USA

OPENING SESSION

"TRANSLATING HIV SCIENCE INTO POPULATION IMPACT: A REALITY CHECK FROM THE FRONTLINE" by Alex Godwin Coutinho of Independent Consultant,, Uganda

MONDAY PLENARY SESSION

"HIV CURE FROM BENCH TO BEDSIDE" by Sharon R. Lewin of University of Melbourne, Melbourne, Victoria, Australia

MONDAY PLENARY SESSION

"UNIVERSAL TEST AND TREAT (UTT): LESSONS FROM THE PAST AND FOR THE FUTURE" by Kevin M. De Cock of Centers for Disease Control and Prevention, Nairobi, Kenya

ORAL ABSTRACT: UNDERSTANDING AND PREVENTING HIV REPLICATION

"MECHANISMS OF PSGL-1 AND CD43 RESTRICTION OF HIV INFECTION OF CD4 T CELLS" by Yuntao Wu of George Mason University, Manassas, VA, USA

ORAL ABSTRACT: UNDERSTANDING AND PREVENTING HIV REPLICATION

"STRUCTURAL ANALYSES OF A BOUND ANTI-CD4 ADNECTIN INHIBITOR OF HIV-1" by David Wensel of ViiV Healthcare, Branford, CT, USA

ORAL ABSTRACT: UNDERSTANDING AND PREVENTING HIV REPLICATION

"SERINC3/5 PERTURB HIV MEMBRANE FUSION POST-HEMIFUSION AT FUSION-PORE DILATION STEPS" by Amanda E Ward of University of Virginia, Charlottesville, VA, USA

ORAL ABSTRACT: UNDERSTANDING AND PREVENTING HIV REPLICATION

"CRISPR-INDUCED MUTAGENESIS POINTS TOWARD A ROLE OF TRN-SR2 IN HIV NUCLEAR IMPORT" by Frauke Christ of Katholieke University Leuven, Leuven, Belgium

ORAL ABSTRACT: UNDERSTANDING AND PREVENTING HIV REPLICATION

"NUCLEAR UNCOATING OF HIV-1 OCCURS NEAR SITES OF INTEGRATION" by Ryan C Burdick of National Cancer Institute, Frederick, MD, USA

ORAL ABSTRACT: UNDERSTANDING AND PREVENTING HIV REPLICATION

"RECONSTITUTION OF HIV-1 CAPSID-DEPENDENT REPLICATION AND INTEGRATION IN VITRO" by Devin E Christensen of University of Utah, Salt Lake City, UT, USA

ORAL ABSTRACT: UNDERSTANDING AND PREVENTING HIV REPLICATION

"STRUCTURAL BASIS OF SECOND-GENERATION HIV INTEGRASE INHIBITOR ACTION AND VIRUS ESCAPE" by Peter Cherepanov of Francis Crick Institute, London, United Kingdom

ORAL ABSTRACT: UNDERSTANDING AND PREVENTING HIV REPLICATION

"THE CHROMATIN LANDSCAPE AT THE HIV-1 INTEGRATION SITE DETERMINES VIRAL EXPRESSION" by Zeger Debyser of KU Leuven, Leuven, Belgium

ORAL ABSTRACT: NOVEL ASSESSMENTS OF CENTRAL NERVOUS SYSTEM PATHOGENESIS

"SINGLE-CELL GENOMIC ANALYSIS OF BLOOD AND CSF T CELLS IN HIV+ AND HIV– ADULTS" by Shelli Farhadian of Yale School of Medicine, New Haven, CT, USA

ORAL ABSTRACT: NOVEL ASSESSMENTS OF CENTRAL NERVOUS SYSTEM PATHOGENESIS

"GREATER BURDEN OF INTRACRANIAL ARTERIAL-WALL ENHANCEMENT IN PERSONS LIVING WITH HIV" by Felicia C Chow of University of California San Francisco, San Francisco, CA, USA

ORAL ABSTRACT: NOVEL ASSESSMENTS OF CENTRAL NERVOUS SYSTEM PATHOGENESIS

"PET IMAGING OF SYNAPTIC DENSITY IN HIV: PRELIMINARY FINDINGS FROM A PILOT STUDY" by Julian Weiss of Yale University, New Haven, CT, USA

ORAL ABSTRACT: NOVEL ASSESSMENTS OF CENTRAL NERVOUS SYSTEM PATHOGENESIS

"HIV-INFECTED MACROPHAGES EVADE NK CELL-MEDIATED KILLING WHILE DRIVING INFLAMMATION" by Kiera L Clayton of Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA

ORAL ABSTRACT: NOVEL ASSESSMENTS OF CENTRAL NERVOUS SYSTEM PATHOGENESIS

"HIV DNA DETECTED IN IMMUNE CELL SUBSETS IN CSF DURING ART" by Joshua Charles Cyktor of University of Pittsburgh, Pittsburgh, PA, USA

ORAL ABSTRACT: NOVEL ASSESSMENTS OF CENTRAL NERVOUS SYSTEM PATHOGENESIS

"EFFECTS OF HIV AND AGING ON RESTING-STATE NETWORKS" by Patrick Luckett of Washington University in St Louis, St Louis, MO, USA

ORAL ABSTRACT: NOVEL ASSESSMENTS OF CENTRAL NERVOUS SYSTEM PATHOGENESIS

"MYELIN CONTENT IS ELEVATED IN VIROLOGICALLY UNSUPPRESSED PEOPLE LIVING WITH HIV" by Dimitre Tomov of Washington University, St Louis, MO, USA

ORAL ABSTRACT: THERAPEUTIC INTERVENTIONS FOR HIV TREATMENT AND ERADICATION

"CABOTEGRAVIR + RILPIVIRINE EVERY 2 MONTHS IS NONINFERIOR TO MONTHLY: ATLAS-2M STUDY" by Edgar Turner Overton of University of Alabama, Birmingham, AL, USA

ORAL ABSTRACT: THERAPEUTIC INTERVENTIONS FOR HIV TREATMENT AND ERADICATION

"PROSPECTIVE ENHANCED MONITORING OF DOLUTEGRAVIR-BASED FIRST LINE IN MALAWI" by Elvis Temfack of Medecins Sans Frontieres, Blantyre, Malawi

ORAL ABSTRACT: THERAPEUTIC INTERVENTIONS FOR HIV TREATMENT AND ERADICATION

"RANDOMIZED SWITCH TO B/F/TAF IN AFRICAN AMERICAN ADULTS WITH HIV" by Debbie P Hagins of Chatham CARE Center, Savannah, GA, USA

ORAL ABSTRACT: THERAPEUTIC INTERVENTIONS FOR HIV TREATMENT AND ERADICATION

"IMPACT OF ANTI-PD-1 AND ANTI-CTLA-4 ON THE HIV RESERVOIR IN VIVO: THE AMC-095 STUDY" by Thomas Aagaard Rasmussen of University of Melbourne, Melbourne, Victoria, Australia

ORAL ABSTRACT: THERAPEUTIC INTERVENTIONS FOR HIV TREATMENT AND ERADICATION

"A RANDOMIZED TRIAL OF THE IMPACT OF 3BNC117 AND ROMIDEPSIN ON THE HIV-1 RESERVOIR" by Ole Schmeltz Søgaard of Aarhus University Hospital, Aarhus N, Denmark

ORAL ABSTRACT: THERAPEUTIC INTERVENTIONS FOR HIV TREATMENT AND ERADICATION

"SAFETY & PHARMACOKINETICS OF GS-9722 IN HIV-NEGATIVE PARTICIPANTS AND PEOPLE WITH HIV" by Peter Ruane of Peter J Ruane, MD Inc, Los Angeles, CA, USA

ORAL ABSTRACT: THERAPEUTIC INTERVENTIONS FOR HIV TREATMENT AND ERADICATION

"SAFETY AND ANALYTIC TREATMENT INTERRUPTION OUTCOMES OF VESATOLIMOD IN HIV CONTROLLERS" by Devi Sengupta of Gilead Sciences, Foster City, CA, USA

ORAL ABSTRACT: THERAPEUTIC INTERVENTIONS FOR HIV TREATMENT AND ERADICATION

"DURABLE HIV-1 ANTIBODY PRODUCTION IN HUMANS AFTER AAV8-MEDIATED GENE TRANSFER" by Joseph P Casazza of National Institutes of Health, USA, Bethesda, MD, USA

ORAL ABSTRACT: COMMUNITY- AND CLINIC-BASED HIV TREATMENT, PREVENTION INTERVENTIONS, AND INSIGHTS

"INDEX FACTORS INCREASE PARTNER NOTIFICATION YIELD FOR KENYAN PEOPLE WHO INJECT DRUGS" by Brandon Guthrie of University of Washington, Seattle, WA, USA

ORAL ABSTRACT: COMMUNITY- AND CLINIC-BASED HIV TREATMENT, PREVENTION INTERVENTIONS, AND INSIGHTS

"COMMUNITY-BASED MULTIMONTH DISPENSING OF ART: A CLUSTER RANDOMISED TRIAL IN LESOTHO" by Betty Bawuba Tukei of Right to Care, Maseru, Lesotho

ORAL ABSTRACT: COMMUNITY- AND CLINIC-BASED HIV TREATMENT, PREVENTION INTERVENTIONS, AND INSIGHTS

"AN MHEALTH CHW INTERVENTION TRIAL IN AN HIV HYPERENDEMIC COMMUNITY IN RAKAI, UGANDA" by Larry W Chang of Johns Hopkins University School of Medicine, Baltimore, MD, USA

ORAL ABSTRACT: COMMUNITY- AND CLINIC-BASED HIV TREATMENT, PREVENTION INTERVENTIONS, AND INSIGHTS

"IMPROVED TIME IN CARE AND VIRAL SUPPRESSION WITH STREAMLINED CARE IN THE SEARCH STUDY" by Matthew D Hickey of University of California San Francisco, San Francisco, CA, USA

ORAL ABSTRACT: COMMUNITY- AND CLINIC-BASED HIV TREATMENT, PREVENTION INTERVENTIONS, AND INSIGHTS

"COLLABORATIVE DATA-TO-CARE MODEL IMPROVES HIV CARE OUTCOMES IN PLWH IN PHILADELPHIA" by Kathleen Anne Brady of Philadelphia Department of Public Health, Philadelphia, PA, USA

ORAL ABSTRACT: COMMUNITY- AND CLINIC-BASED HIV TREATMENT, PREVENTION INTERVENTIONS, AND INSIGHTS

"POPULATION-LEVEL VIREMIA PREDICTS HIV INCIDENCE ACROSS UNIVERSAL TEST & TREAT STUDIES" by Maya L Petersen of University of California, Berkeley, Berkeley, CA, USA

ORAL ABSTRACT: COMMUNITY- AND CLINIC-BASED HIV TREATMENT, PREVENTION INTERVENTIONS, AND INSIGHTS

"DECREASING COMMUNITY VIREMIA IS ASSOCIATED WITH DECREASING HIV INCIDENCE IN AUSTRALIA" by Denton James Callander of UNSW Sydney, Sydney, NSW, Australia

ORAL ABSTRACT: COMMUNITY- AND CLINIC-BASED HIV TREATMENT, PREVENTION INTERVENTIONS, AND INSIGHTS

"COMMUNITY ART INCREASES VIRAL SUPPRESSION AND ELIMINATES DISPARITIES FOR AFRICAN MEN" by Ruanne V Barnabas of University of Washington, Seattle, WA, USA

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"SESSION INTRODUCTION" by Alan N. Engelman of Dana-Farber Cancer Institute, Boston, MA, USA

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"HIV-1 CAPSID-NUCLEAR ENVELOPE INTERACTIONS THAT FACILITATE NUCLEAR IMPORT" by Mohamed Husen Munshi of National Cancer Institute, Frederick, MD, USA

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"REPORTER VIRUSES WITH PROTEIN BARCODES TO ANALYZE HIV LATENCY ESTABLISHMENT" by Eun Hye Grace Kim of Icahn School of Medicine at Mt Sinai, New York, NY, USA

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"GAG DETERMINANTS OF SPECIFIC GENOME PACKAGING IN HIV-1 AND HIV-2" by Jonathan Rawson of National Cancer Institute, Frederick, MD, USA

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"EXPLORING THE REQUIREMENTS FOR HIV-1 GENOME PACKAGING THROUGH A NONVIRAL RNA BINDING" by Alice Duchon of National Cancer Institute, FREDERICK, MD, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"SESSION INTRODUCTION" by Markella V Zanni of Massachusetts General Hospital, Boston, MA, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"TESTOSTERONE THERAPY AND SUBCLINICAL ATHEROSCLEROSIS PROGRESSION AMONG MEN WITH HIV" by Sabina A. Haberlen of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"POSTDISCHARGE OUTCOMES FOLLOWING ACUTE CORONARY SYNDROME IN HIV" by Monica Parks of University of California San Francisco, San Francisco, CA, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"INSOMNIA AND RISK OF INCIDENT MYOCARDIAL INFARCTION AMONG PEOPLE LIVING WITH HIV" by Bridget M Whitney of University of Washington, Seattle, WA, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"HORMONE USE AND HIV ALTER CARDIOVASCULAR BIOMARKER PROFILES IN TRANSGENDER WOMEN" by Jordan E Lake of University of Texas Health Science Center Houston, Houston, TX, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"HIV SEVERITY AND INCIDENT HEART FAILURE AMONG PATIENTS IN A LARGE HEALTH CARE SYSTEM" by Jennifer O. Lam of Kaiser Permanente, Oakland, CA, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"SESSION INTRODUCTION" by Risa M. Hoffman of David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"CHANGES IN BONE MINERAL DURING AND AFTER LACTATION IN UGANDAN WOMEN ON OPTION B+ ART" by Mary Glenn Fowler of Johns Hopkins University, Baltimore, MD, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"POSTPARTUM WEIGHT CHANGES IN WOMEN INITIATING DTG VS EFV IN PREGNANCY: DOLPHIN-2" by Thokozile Rosemary Malaba of University of Cape Town, Cape Town, South Africa

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"DOLUTEGRAVIR USE IS ASSOCIATED WITH HIGHER POSTPARTUM WEIGHT COMPARED TO EFAVIRENZ" by Jennifer Jao of Northwestern University Feinberg School of Medicine, Chicago, IL, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"FACTORS ASSOCIATED WITH GESTATIONAL DIABETES IN HIV+ AND HIV– WOMEN IN PUNE, INDIA" by Puja Chebrolu of Weill Cornell Medicine, Columbus, GA, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"HIGH BLOOD PRESSURE AND ADVERSE BIRTH OUTCOMES IN HIV+ AND HIV– SOUTH AFRICAN WOMEN" by Angela Bengtson of Brown University, Providence, RI, USA

THEMED DISCUSSION: RAPID ART START: WHERE ARE THE GAPS?

"ASSOCIATION BETWEEN TIME TO ART AND LOSS TO CARE AMONG NEWLY DIAGNOSED PLWH IN RWANDA" by Jonathan Ross of Montefiore Medical Center / Albert Einstein College of Medicine, Bronx, NY, USA

THEMED DISCUSSION: RAPID ART START: WHERE ARE THE GAPS?

"SAME-DAY ART IN THAILAND: THE IMPACT OF ART INITIATION PERIODS ON TREATMENT OUTCOMES" by Pich Seekaew of Columbia University, New York, NY, USA

THEMED DISCUSSION: RAPID ART START: WHERE ARE THE GAPS?

"RAPID START LEADS TO SUSTAINED VIRAL SUPPRESSION IN YOUNG PEOPLE IN THE SOUTH" by Jason Halperin of CrescentCare, New Orleans, LA, USA

THEMED DISCUSSION: RAPID ART START: WHERE ARE THE GAPS?

"ASSESSMENT OF IMMEDIATE INITIATION OF ANTIRETROVIAL THERAPY IN NEW YORK CITY" by Daniel Bertolino of New York City Department of Health and Mental Hygiene, Queens, NY, USA

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"SESSION INTRODUCTION" by Rachel Baggaley of World Health Organization, Geneva, Switzerland

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"ASSISTED PARTNER NOTIFICATION SERVICES IN KAMPALA, UGANDA" by Florence Namimbi of Infectious Diseases Institute, Kampala, Uganda

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"TARGETED PEER MOBILISATION AND ASSISTED PARTNER NOTIFICATION SERVICES IN KENYA" by Maartje Dijkstra of Public Health Service Amsterdam, Amsterdam, NE, Netherlands

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"SCALE-UP OF ASSISTED PARTNER SERVICES (APS) IN BOTSWANA" by Matthew R Golden of University of Washington, Seattle, WA, USA

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"OPTIMIZING TESTING INCREASES YIELD IN HIV CASE FINDING IN 24 COUNTRIES, 2018–2019" by Shahul Hameed Ebrahim of Centers for Disease Control, atlanta, GA, USA

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"COMPARISON OF INDEX TESTING APPROACHES TO IMPROVE HIV-TESTING EFFICIENCY IN RWANDA" by Eric Remera of RWANDA BIOMEDICAL CENTRE, kigali, Rwanda

SYMPOSIUM: NOVEL CURE INTERVENTIONS

"IN VIVO MODELS FOR THE EVALUATION OF NOVEL HIV CURE INTERVENTIONS" by J. Victor Garcia-Martinez of University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

SYMPOSIUM: NOVEL CURE INTERVENTIONS

"LRA 2.0: IMMUNE-BASED LATENCY REVERSAL" by Ann Chahroudi of Emory University, Atlanta, GA, USA

SYMPOSIUM: NOVEL CURE INTERVENTIONS

"T-CELL AND HEMATOPOIETIC STEM CELL GENE THERAPIES FOR HIV CURE" by Christopher Peterson of Fred Hutchinson Cancer Research Center, Seattle, USA

SYMPOSIUM: NOVEL CURE INTERVENTIONS

"TOWARD DURABLE CONTROL OF HIV-1 WITH ECD4-IG" by Michael Farzan of The Scripps Research Institute, Jupiter, FL, USA

SYMPOSIUM: HISTORY REPEATING ITSELF: SEXUALLY TRANSMITTED INFECTIONS IN WOMEN AND INFANTS

"SYPHILIS CAUSES STILLBIRTH: PENICILLIN IS PREVENTION" by Melanie Taylor of World Health Organization, Geneva, Switzerland

SYMPOSIUM: HISTORY REPEATING ITSELF: SEXUALLY TRANSMITTED INFECTIONS IN WOMEN AND INFANTS

"CHLAMYDIA AND GONORRHOEA IN PREGNANCY: SILENCE OF THE GERMS" by Nicola Low of University of Bern, Bern, Switzerland

SYMPOSIUM: HISTORY REPEATING ITSELF: SEXUALLY TRANSMITTED INFECTIONS IN WOMEN AND INFANTS

"MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B: CAN IT BE ELIMINATED?" by Yusuke Shimakawa of Institut Pasteur, Paris, France

SYMPOSIUM: HISTORY REPEATING ITSELF: SEXUALLY TRANSMITTED INFECTIONS IN WOMEN AND INFANTS

"BEYOND THE STIGMA: A SORELY NEEDED PERSPECTIVE ON HSV" by Anna Wald of University of Washington, Seattle, WA, USA

SYMPOSIUM: WHAT MAKES EPIDEMICS RECEDE

"REFLECTIONS ON THE UK EPIDEMIC" by Valerie Delpech of Public Health England, London, United Kingdom

SYMPOSIUM: WHAT MAKES EPIDEMICS RECEDE

"30-PLUS YEARS OF HIV IN RAKAI: THE EPIDEMIC RECEDES" by Joseph Kagaayi of Makerere University school of Public Health, and Rakai Health Science Program, Kampala, Uganda

SYMPOSIUM: WHAT MAKES EPIDEMICS RECEDE

"BATTLING HIV IN THE US RURAL SOUTH" by Leandro Antonio Mena of University of Mississippi Medical Center, Jackson, MS, USA

SYMPOSIUM: WHAT MAKES EPIDEMICS RECEDE

"HOW DO WE STOP THE BAND FROM PLAYING ON IN THE US?" by Carlos Del Rio of Emory University, Atlanta, GA, USA

TUESDAY PLENARY SESSION

"PREVENTING HIV AMONG PEOPLE WHO INJECT DRUGS: PLUS ÇA CHANGE, PLUS ÇA MÊME CHOSE" by Steffanie A Strathdee of University of California San Diego, La Jolla, CA, USA

TUESDAY PLENARY SESSION

"SEX DIFFERENCES IN HIV" by Eileen P Scully of Johns Hopkins University, Baltimore, MD, USA

ORAL ABSTRACT: HIV-ASSOCIATED MALIGNANCIES AND TUMOR VIRUSES: AN EXPANDING LANDSCAPE

"TARGETING THE KSHV TYROSINE KINASE AND VIRAL LYTIC REACTIVATION WITH INHIBITORS" by Thomas F. Schulz of Medizinische Hochschule Hannover, Hannover, Germany

ORAL ABSTRACT: HIV-ASSOCIATED MALIGNANCIES AND TUMOR VIRUSES: AN EXPANDING LANDSCAPE

"A ROLE FOR IRON METABOLISM AND FERROPTOSIS IN KAPOSI SARCOMA HERPESVIRUS PATHOGENESIS" by Ashlee Vivien Moses of Oregon Health & Science University, Beaverton, OR, USA

ORAL ABSTRACT: HIV-ASSOCIATED MALIGNANCIES AND TUMOR VIRUSES: AN EXPANDING LANDSCAPE

"GENE EXPRESSION PATTERNS IN SKIN VS GASTROINTESTINAL KAPOSI SARCOMA LESIONS" by Joseph Ziegelbauer of National Institutes of Health, Bethesda, MD, USA

ORAL ABSTRACT: HIV-ASSOCIATED MALIGNANCIES AND TUMOR VIRUSES: AN EXPANDING LANDSCAPE

"IMPACT OF VALGANCICLOVIR THERAPY ON SEVERE IRIS–KAPOSI SARCOMA–ATTRIBUTABLE MORTALITY" by Patricia Volkow of Instituto Nacional de Cancerologia, Mexico City, Mexico

ORAL ABSTRACT: HIV-ASSOCIATED MALIGNANCIES AND TUMOR VIRUSES: AN EXPANDING LANDSCAPE

"SURVEILLANCE OF RHESUS MACAQUE TISSUES IDENTIFYING GAMMAHERPESVIRUS INFECTION SITES" by Catherine Brands of Frederick National Laboratory for Cancer Research, Frederick, MD, USA

ORAL ABSTRACT: HIV-ASSOCIATED MALIGNANCIES AND TUMOR VIRUSES: AN EXPANDING LANDSCAPE

"CONJUNCTIVAL CANCER IN PEOPLE LIVING WITH HIV: THE SAM STUDY" by Tafadzwa G Dhokotera of Institute of Social and Preventative Medicine, University of Bern, Switzerland, Bern, Switzerland

ORAL ABSTRACT: HIV-ASSOCIATED MALIGNANCIES AND TUMOR VIRUSES: AN EXPANDING LANDSCAPE

"CLEARANCE OF HPV ANAL HIGH-GRADE INTRAEPITHELIAL LESIONS WITH LOW-DOSE POMALIDOMIDE" by Mark Polizzotto of The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia

ORAL ABSTRACT: HIV-ASSOCIATED MALIGNANCIES AND TUMOR VIRUSES: AN EXPANDING LANDSCAPE

"INCREASED CANCER RISK WITH LOWER CD4/CD8 RATIO AMONG ADULTS WITH HIV IN NA-ACCORD" by Jessica L. Castilho of Vanderbilt University Medical Center, Nashville, TN, USA

ORAL ABSTRACT: TARGETING THE PERSISTENT HIV RESERVOIR

"WHOLE-BODY PET IMAGING OF THE HIV RESERVOIR USING RADIOLABELED VRC01" by Timothy J Henrich of UCSF, San Francisco, CA, USA

ORAL ABSTRACT: TARGETING THE PERSISTENT HIV RESERVOIR

"ANTIGEN-DRIVEN CLONAL SELECTION SHAPES THE FATE OF HIV-INFECTED CD4+ T CELLS IN VIVO" by Francesco Roberto Simonetti of Johns Hopkins University, Baltimore, MD, USA

ORAL ABSTRACT: TARGETING THE PERSISTENT HIV RESERVOIR

"DISTINCT CHROMOSOMAL INTEGRATION SITE CONFIGURATION IN HIV-1 ELITE CONTROLLERS" by Chenyang Jiang of Brigham and Women's Hospital, Cambridge, MA, USA

ORAL ABSTRACT: TARGETING THE PERSISTENT HIV RESERVOIR

"INTACT PROVIRAL DNA LEVELS DECLINE IN PEOPLE WITH HIV ON ANTIRETROVIRAL THERAPY" by Rajesh T Gandhi of Massachusetts General Hospital, Boston, MA, USA

ORAL ABSTRACT: TARGETING THE PERSISTENT HIV RESERVOIR

"CHIMERIC ANTIGEN RECEPTOR T CELLS CONTROL SHIV REPLICATION IN POST-ATI MACAQUES" by Blake Rust of Fred Hutchinson Cancer Research Center, Seattle, WA, USA

ORAL ABSTRACT: TARGETING THE PERSISTENT HIV RESERVOIR

"DELAY IN VIRAL REBOUND WITH TLR7 AGONIST, N6-LS, AND PGT121 IN SHIV-INFECTED MACAQUES" by Denise C Hsu of US Military HIV Research Program, Bangkok, Thailand

ORAL ABSTRACT: TARGETING THE PERSISTENT HIV RESERVOIR

"COMBINED ACTIVE AND PASSIVE IMMUNIZATION IN SHIV-INFECTED RHESUS MONKEYS" by Dan Barouch of Beth Israel Deaconess Medical Center, Boston, MA, USA

ORAL ABSTRACT: TARGETING THE PERSISTENT HIV RESERVOIR

"COMBINATION IL-15 THERAPY IN A SHIV NHP MODEL" by James Whitney of Beth Israel Deaconess Medical Center, Boston, MA, USA

ORAL ABSTRACT: TARGETING THE PERSISTENT HIV RESERVOIR

"QUESTIONS AND ANSWERS" by of

ORAL ABSTRACT: CARDIOMETABOLIC AND PULMONARY COMPLICATIONS

"A MENDELIAN RANDOMIZATION ANALYSIS OF PROTEIN BIOMARKERS AND CVD IN PERSONS WITH HIV" by Cavan Reilly of University of Minnesota, Minneapolis, MN, USA

ORAL ABSTRACT: CARDIOMETABOLIC AND PULMONARY COMPLICATIONS

"RISKS OF METABOLIC SYNDROME, DIABETES, AND CARDIOVASCULAR DISEASE IN ADVANCE TRIAL" by Andrew Hill of University of Liverpool, Liverpool, United Kingdom

ORAL ABSTRACT: CARDIOMETABOLIC AND PULMONARY COMPLICATIONS

"CYP2B6 GENOTYPE AND WEIGHT-GAIN DIFFERENCES BETWEEN DOLUTEGRAVIR AND EFAVIRENZ" by Rulan Griesel of University of Cape Town, Cape Town, Western Cape, South Africa

ORAL ABSTRACT: CARDIOMETABOLIC AND PULMONARY COMPLICATIONS

"CHANGES IN BODY MASS INDEX AND THE RISK OF CARDIOVASCULAR DISEASE: THE D:A:D STUDY" by Kathy Petoumenos of The Kirby Institute, UNSW Sydney, Sydney, Australia

ORAL ABSTRACT: CARDIOMETABOLIC AND PULMONARY COMPLICATIONS

"LOSARTAN TO REDUCE INFLAMMATION AND FIBROSIS ENDPOINTS IN HIV DISEASE (LIFE-HIV)" by Jason V Baker of Hennepin Healthcare Research Institute, Minneapolis, MN, USA

ORAL ABSTRACT: CARDIOMETABOLIC AND PULMONARY COMPLICATIONS

"EFFECTS OF HIV INFECTION AND IMMUNE REGULATION ON LONGITUDINAL LUNG FUNCTION DECLINE" by Jing Sun of Johns Hopkins University, Baltimore, MD, USA

ORAL ABSTRACT: CARDIOMETABOLIC AND PULMONARY COMPLICATIONS

"AZITHROMYCIN FOR TREATMENT OF HIV-RELATED CHRONIC LUNG DISEASE IN AFRICAN CHILDREN" by Rashida Abbas Ferrand of London School of Hygiene and Tropical Medicine, London, United Kingdom

ORAL ABSTRACT: PREVENTION 2020: AGENTS, OPTIONS, AND OUTCOMES

"BIC/FTC/TAF POSTEXPOSURE PROPHYLAXIS PROTECTS MACAQUES AGAINST RECTAL SHIV INFECTION" by Elena Bekerman of Gilead Sciences Inc, Foster City, CA, USA

ORAL ABSTRACT: PREVENTION 2020: AGENTS, OPTIONS, AND OUTCOMES

"ON-DEMAND HIV POSTEXPOSURE PROPHYLAXIS BY TAF/EVG VAGINAL INSERTS IN MACAQUES" by Charles Dobard of CDC, atlanta, GA, USA

ORAL ABSTRACT: PREVENTION 2020: AGENTS, OPTIONS, AND OUTCOMES

"WEEKLY ORAL ISLATRAVIR PROVIDES EFFECTIVE PEP AGAINST IV CHALLENGE WITH SIVMAC251" by Jay Grobler of Merck & Co, West Point, PA, USA

ORAL ABSTRACT: PREVENTION 2020: AGENTS, OPTIONS, AND OUTCOMES

"PHASE I PLACEBO-CONTROLED SAFETY, PK, AND PD STUDY OF MB66 ANTI-HIV AND ANTI-HSV FILM" by Susan Cu-Uvin of The MIriam Hospital, Providence, RI, USA

ORAL ABSTRACT: PREVENTION 2020: AGENTS, OPTIONS, AND OUTCOMES

"NEAR-PERFECT ACCURACY OF A REAL-TIME URINE TENOFOVIR TEST COMPARED TO LAB-BASED ELISA" by Matthew A Spinelli of University of California San Francisco, San Francisco, CA, USA

ORAL ABSTRACT: PREVENTION 2020: AGENTS, OPTIONS, AND OUTCOMES

"LONGER-TERM SAFETY OF F/TAF AND F/TDF FOR HIV PREP: DISCOVER TRIAL WEEK-96 RESULTS" by Onyema Ogbuagu of Yale School of Medicine, New Haven, CT, USA

ORAL ABSTRACT: PREVENTION 2020: AGENTS, OPTIONS, AND OUTCOMES

"INITIATING PREP DURING ACUTE HIV INFECTION: WHAT IS THE RISK FOR ARV DRUG RESISTANCE?" by Donn J Colby of Thai Red Cross AIDS Research Centre, Seattle, WA, USA

ORAL ABSTRACT: PREVENTION 2020: AGENTS, OPTIONS, AND OUTCOMES

"PEPFAR DREAMS INTERVENTION AMONG ADOLESCENT GIRLS AND YOUNG WOMEN IN RAKAI, UGANDA" by Hadijja Nakawooya of Rakai Health Sciences Program, KALISIZO TOWN, Uganda

SYMPOSIUM: SPECIAL LUNCHTIME SESSION ON COVID-19

"GLOBAL EPIDEMIOLOGY AND PREVENTION OF COVID-19" by John T Brooks of Centers for Disease Control and Prevention, Atlanta, GA, USA

SYMPOSIUM: SPECIAL LUNCHTIME SESSION ON COVID-19

"VIROLOGY OF CORONAVIRUSES" by Ralph S Baric of University of North Carolina Chapel Hill, Chapel Hill, NC, USA

SYMPOSIUM: SPECIAL LUNCHTIME SESSION ON COVID-19

"OUTBREAK OF COVID-19 IN CHINA AND THE COUNTRY'S RESPONSES" by Zunyou Wu of

SYMPOSIUM: SPECIAL LUNCHTIME SESSION ON COVID-19

"THE RESEARCH RESPONSE TO COVID-19: A VIEW FROM NIAID" by Anthony S Fauci of National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA

SYMPOSIUM: SPECIAL LUNCHTIME SESSION ON COVID-19

"QUESTIONS AND ANSWERS" by of

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"SESSION INTRODUCTION" by Pablo Tebas of University of Pennsylvania, Philadelphia, PA, USA

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"EFFECT OF TAMOXIFEN ON VORINOSTAT-INDUCED HIV RNA EXPRESSION IN WOMEN ON ART (A5366)" by Eileen P Scully of Johns Hopkins University, Baltimore, MD, USA

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"EFFECTS OF IMMUNE CHECKPOINT THERAPY ON LATENT HIV IN PEOPLE WITH HIV AND MALIGNANCY" by Jillian SY Lau of Alfred Hospital, Glen Iris, VIC, Australia

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"ABX464 DECREASES THE TOTAL HIV RESERVOIR AND HIV TRANSCRIPTION INITIATION IN VIVO" by Sara Moron-Lopez of University of California San Francisco - SFVAMC - NCIRE, San Francisco, CA, USA

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"ATTACKING LATENT HIV WITH CONVERTIBLE CAR-T CELLS, A MODULAR KILLING PLATFORM" by Eytan Herzig of University of California San Francisco, San Francisco, CA, USA

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"CAR-T CELLS AT 15 YEARS: PERSISTENCE OF CD4-ZETA TRANSGENE AND EFFECT ON RESERVOIR" by Naomi E Aronson of Uniformed Services University, Bethesda, MD, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"SESSION INTRODUCTION" by Avindra Nath of National Institutes of Health, Bethesda, MD, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"CONSERVED CSF HIV ANTIBODY RESPONSE IN PATIENTS WITH DIVERSE NEUROLOGIC PHENOTYPES" by Isobel Anne Hawes of University of California San Francisco, San Francisco, CA, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"CNS HIV BEARS ENVELOPE MARKERS CONSISTENT WITH T-CELL ORIGIN IN THE FACE OF ART" by Alex Sigal of Africa Health Research Institute (AHRI), Durban, KwaZulu-Natal, South Africa

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"RETINAL THINNING CORRELATES WITH BRAIN ATROPHY IN WELL-CONTROLLED HIV INFECTION" by Bryan Smith of National institutes of Health, Bethesda, MD, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"BIOMARKERS OF NUCLEIC ACID OXIDATION AND NEURODEGENERATION IN CSF IN PWH" by Ronald J. Ellis of University of California, San Diego, CA, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"PREDICTIVE VALIDATION OF AN UGANDAN INFANT EYE-TRACKING TEST OF MEMORY OF HUMAN FACES" by Michael Joseph Boivin of Michigan State University, East Lansing, MI, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"MODERATED DISCUSSION" by of

THEMED DISCUSSION: FAT IN FOCUS

"SESSION INTRODUCTION" by Jacqueline Capeau of Sorbonne University, PARIS, France

THEMED DISCUSSION: FAT IN FOCUS

"FAT GAINS OCCUR AFTER ART WITHOUT CHANGES IN METABOLIC RATE OR CALORIC INTAKE" by Allison Ross Eckard of Medical University of South Carolina, Charleston, SC, USA

THEMED DISCUSSION: FAT IN FOCUS

"GREATER WEIGHT GAIN AFTER SWITCH TO INSTI-BASED REGIMEN FROM NNRTI VS PI REGIMENS" by John Koethe of Vanderbilt University Medical Center, Nashville, TN, USA

THEMED DISCUSSION: FAT IN FOCUS

"BODY COMPOSITION CHANGES OVER THE MENOPAUSAL TRANSITION IN HIV+ AND HIV– WOMEN" by Phyllis Tien of UCSF, San Francisco, CA, USA

THEMED DISCUSSION: FAT IN FOCUS

"RESISTIN GENE POLYMORPHISM RELATED TO WEIGHT GAIN AND PSYCHIATRIC SYMPTOMS ON INSTI" by Rumi Minami of National Hospital Organization Kyushu Medical Center, Fukuoka, Japan

THEMED DISCUSSION: FAT IN FOCUS

"ADIPOCYTE DYSFUNCTION DESPITE REDUCED ADIPOSE INFLAMMATION IN DIABETICS WITH HIV" by Samuel Bailin of Vanderbilt University Medical Center, Nashville, TN, USA

THEMED DISCUSSION: FAT IN FOCUS

"CONCLUSION" by Jacqueline Capeau of Sorbonne University, PARIS, France

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"SESSION INTRODUCTION" by Adrie Bekker of Stellenbosch University, Cape Town, South Africa

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"IDENTIFICATION OF AGE-APPROPRIATE DOSING STRATEGIES OF BICTEGRAVIR IN NEONATES" by Fazila Sadik Bunglawala of University of Liverpool, Liverpool, United Kingdom

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"MARAVIROC SAFETY & PHARMACOKINETICS IN HIV-EXPOSED NEONATES" by Julia C Rosebush of The University of Chicago, Chicago, IL, USA

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"ABACAVIR SAFETY AND PHARMACOKINETICS IN NORMAL AND LOW BIRTH WEIGHT INFANTS WITH HIV" by Tim R. Cressey of Harvard T.H. Chan School of Public Health / PHPT-IRD 174, Chiang Mai, Chiang Mai, Thailand

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"ADEQUATE DOLUTEGRAVIR EXPOSURE DOSED BID WITH RIFAMPICIN IN CHILDREN 6 TO <18 YEARS" by Hylke Waalewijn of Radboud University Medical Centre, Amsterdam, Netherlands

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"ABACAVIR SAFETY AND EFFICACY IN YOUNG INFANTS IN SOUTH AFRICAN OBSERVATIONAL COHORTS" by Renee De Waal of University of Cape Town, Cape Town, South Africa

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"SESSION INTRODUCTION" by Sari L Reisner of Harvard T.H. Chan School of Public Health, Boston, MA, USA

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"PREEXPOSURE PROPHYLAXIS ADHERENCE AND PERSISTENCE IN KENYAN TRANSGENDER WOMEN AND MSM" by Makobu Kimani of Kenya Medical Research Institute (KEMRI), Kilifi, Kenya

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"HIV PREVALENCE AND RISK IN MALE‚ TRANSMALE, AND TRANSFEMALE SEX WORKERS IN ZIMBABWE" by Jan Anton Charles Hontelez of Erasmus University Medical Center, Rotterdam, Netherlands

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"FACTORS ASSOCIATED WITH HIV, HCV, AND HSV-2 SEROSTATUS AMONG US TRANSGENDER WOMEN" by Morgan P Keruly of NIH, Baltimore, MD, USA

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"HIV PREVALENCE AMONG TRANSGENDER MEN AT AN NYC COMMUNITY HEALTH CENTER" by Asa Radix of Callen-Lorde Community Health Center, New York, NY, USA

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"PROGRESSION THROUGH THE HIV CARE CONTINUUM FOR TRANSGENDER WOMEN IN THE NA-ACCORD" by Catherine R Lesko of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

SYMPOSIUM: HALT, WHO GOES THERE? VIRUS SENSING AND RESTRICTION

"STING IN THE TAIL: HOW DNA TRIGGERS IMMUNE RESPONSES TO VIRAL INFECTIONS" by Zhijian (James) Chen of UT Southwestern Medical Center, Dallas, TX, USA

SYMPOSIUM: HALT, WHO GOES THERE? VIRUS SENSING AND RESTRICTION

"TRIM5 RECOGNITION AND RESTRICTION OF HIV-1 AND RETROVIRUSES" by Owen Pornillos of University of Virginia, Charlottesville, VA, USA

SYMPOSIUM: HALT, WHO GOES THERE? VIRUS SENSING AND RESTRICTION

"HIV-1 AVOIDS BEING ZAPPED" by Janet L Smith of University of Michigan, Ann Arbor, MI, USA

SYMPOSIUM: HALT, WHO GOES THERE? VIRUS SENSING AND RESTRICTION

"SERINC STRUCTURE AND RESTRICTION OF HIV-1 INFECTIVITY" by Valerie Pye of The Francis Crick Institute, London, UK, United Kingdom

SYMPOSIUM: HIV IS ON OUR MINDS

"NEUROHIV IN THE GLOBAL CONTEXT: ADVANCING THE CONTINUUM OF CARE AND ACHIEVING EQUITY" by Kiran T Thakur of Columbia University Irving Medical Center, New York, NY, USA

SYMPOSIUM: HIV IS ON OUR MINDS

"HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS AND AGING IN THE GLOBAL SETTING" by John Joska of University of Cape Town, Cape Town, South Africa

SYMPOSIUM: HIV IS ON OUR MINDS

"HIV AND MENTAL HEALTH: THE IMPACT OF THE COMORBIDITY IN RESOURCE-CONSTRAINED SETTINGS" by Bibilola D Oladeji of University of Ibadan, Ibadan, Nigeria

SYMPOSIUM: HIV IS ON OUR MINDS

"CEREBROVASCULAR COMPLICATIONS AND NEUROHIV IN THE GLOBAL SETTING" by Felicia C Chow of University of California San Francisco, San Francisco, CA, USA

SYMPOSIUM: B CURED

"GLOBAL ELIMINATION OF HEPATITIS B VIRUS" by Gilles Wandeler of Bern University Hospital, Bern, Switzerland

SYMPOSIUM: B CURED

"ADAPTING THE IMMUNE RESPONSE TO CURE HEPATITIS B" by Barbara Rehermann of National Institutes of Health, Bethesda, MD, USA

SYMPOSIUM: B CURED

"HEPATITIS B VIRUS: NEW AGENTS" by Raymond T Chung of Massachusetts General Hospital, Boston, MA, USA

SYMPOSIUM: B CURED

"THE MATHEMATICS OF HEPATITIS B CURE" by Alan S. Perelson of Los Alamos National Laboratory, Los Alamos, NM, USA

SYMPOSIUM: CONTRACEPTION AND HIV

"DRUG-DRUG INTERACTIONS: THE UPS AND DOWNS OF ANTIRETROVIRALS PLUS CONTRACEPTIVES" by Kimberly K. Scarsi of University of Nebraska Medical Center, Omaha, NE, USA

SYMPOSIUM: CONTRACEPTION AND HIV

"CONTRACEPTIVE IMPLANT ROLLOUT IN SOUTH AFRICA" by Gregory Petro of University of Cape Town, Observatory, Western Cape, South Africa

SYMPOSIUM: CONTRACEPTION AND HIV

"CONTRACEPTION AND HIV RISK: A CONUNDRUM NO MORE" by Renee Heffron of University of Washington, Seattle, WA, USA

SYMPOSIUM: CONTRACEPTION AND HIV

"THE STATE OF SRHR & HIV SERVICES FOR CISGENDER WOMEN: A COMMUNITY PERSPECTIVE" by Wame Jallow of International Treatment Preparedness Coalition, Gaborone, Botswana

SYMPOSIUM: LATE-BREAKING NEWS: UPDATE FROM THE HVTN 702 VACCINE (UHAMBO) TRIAL

"INTRODUCTION OF HVTN 702 STUDY" by Lawrence Corey of Fred Hutchinson Cancer Research Center, Seattle, WA, USA

SYMPOSIUM: LATE-BREAKING NEWS: UPDATE FROM THE HVTN 702 VACCINE (UHAMBO) TRIAL

"PRESENTATION OF HVTN 702 STUDY DATA" by Glenda Elisabeth Gray of University of the Witwatersrand, Soweto, South Africa

WEDNESDAY PLENARY SESSION

"RECENT ADVANCES IN THE DIAGNOSIS, TREATMENT, AND PREVENTION OF TUBERCULOSIS" by Gavin Churchyard of Aurum Institute, Johannesburg, Gauteng, South Africa

WEDNESDAY PLENARY SESSION

"ENGINEERING VACCINE IMMUNITY" by Shane Crotty of La Jolla Institute for Immunology, La Jolla, CA, USA

ORAL ABSTRACT: IMMUNOLOGY AND PATHOGENESIS OF LENTIVIRUS INFECTIONS

"IL-6 BLOCKADE DECREASES INFLAMMATION AND INCREASES CD127 EXPRESSION IN HIV INFECTION" by Benigno Rodriguez of Case Western Reserve University, Cleveland, OH, USA

ORAL ABSTRACT: IMMUNOLOGY AND PATHOGENESIS OF LENTIVIRUS INFECTIONS

"NEUTRALIZING ANTIBODIES AND TRMS PROVIDE ENHANCED AND DURABLE RESISTANCE AGAINST HIV" by Prabhu S Arunachalam of Stanford University, Palo Alto, CA, USA

ORAL ABSTRACT: IMMUNOLOGY AND PATHOGENESIS OF LENTIVIRUS INFECTIONS

"HUMAN NK CELLS DEVELOP ANTIGEN-SPECIFIC IMMUNOLOGICAL MEMORY OF HIV" by Stephanie Jost of Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA

ORAL ABSTRACT: IMMUNOLOGY AND PATHOGENESIS OF LENTIVIRUS INFECTIONS

"EFFICACIOUS RHCMV/SIV VECTORS ELICIT BROADLY CROSS-REACTIVE SIV-SPECIFIC CD8+ T CELLS" by Benjamin N Bimber of Oregon Health & Science University, Beaverton, OR, USA

ORAL ABSTRACT: IMMUNOLOGY AND PATHOGENESIS OF LENTIVIRUS INFECTIONS

"PD-1 BLOCKADE AT TIME OF ART WITHDRAWAL FACILITATES EARLY POST-PEAK VIRAL CONTROL" by Afam Okoye of Oregon Health and Science University, Beaverton, OR, USA

ORAL ABSTRACT: IMMUNOLOGY AND PATHOGENESIS OF LENTIVIRUS INFECTIONS

"TRACKING AND PREDICTING REBOUND IN SHIV-INFECTED INFANT MACAQUES AFTER LONG-TERM ART" by Veronica Obregon-Perko of Emory University, Atlanta, GA, USA

ORAL ABSTRACT: IMMUNOLOGY AND PATHOGENESIS OF LENTIVIRUS INFECTIONS

"PERIPHERAL BLOOD SIV/HIV ORIGINATES FROM INFECTED CELLS IN TISSUES" by Leticia Kuri Cervantes of University of Pennsylvania, Philadelphia, PA, USA

ORAL ABSTRACT: IMMUNOLOGY AND PATHOGENESIS OF LENTIVIRUS INFECTIONS

"CD4+ T-CELL DEPLETION IN AFRICAN GREEN MONKEYS DOES NOT ALTER DISEASE PROGRESSION" by Christian Apetrei of University of Pittsburgh, Pittsburgh, PA, USA

ORAL ABSTRACT: IMMUNOLOGY AND PATHOGENESIS OF LENTIVIRUS INFECTIONS

"QUESTIONS AND ANSWERS" by of

ORAL ABSTRACT: GONE BUT NOT FORGOTTEN: HCV AFTER DIRECT-ACTING ANTIVIRAL THERAPY

"INFERIORITY OF SHORT DURATION SOFOSBUVIR-VELPATASVIR FOR RECENT HCV (REACT STUDY)" by Gail Matthews of Kirby Institute, Sydney, Australia

ORAL ABSTRACT: GONE BUT NOT FORGOTTEN: HCV AFTER DIRECT-ACTING ANTIVIRAL THERAPY

"INDIVIDUAL AND POPULATION-LEVEL IMPACT OF HCV TREATMENT AMONG PEOPLE WHO INJECT DRUGS" by Javier Cepeda of University of California San Diego, LA JOLLA, CA, USA

ORAL ABSTRACT: GONE BUT NOT FORGOTTEN: HCV AFTER DIRECT-ACTING ANTIVIRAL THERAPY

"LARGE HIV OUTBREAK AMONG PEOPLE WHO INJECT DRUGS, WEST VIRGINIA, 2018–2019" by Robert Paul McClung of Centers for Disease Control and Prevention, Atlanta, GA, USA

ORAL ABSTRACT: GONE BUT NOT FORGOTTEN: HCV AFTER DIRECT-ACTING ANTIVIRAL THERAPY

"HCV TRANSMISSION AMONG MSM: EXTERNAL INTRODUCTIONS COULD COMPLICATE MICRO-ELIMINATION" by Jelle Koopsen of Amsterdam University Medical Center, Amsterdam, Netherlands

ORAL ABSTRACT: GONE BUT NOT FORGOTTEN: HCV AFTER DIRECT-ACTING ANTIVIRAL THERAPY

"NEWBORN TESTING REVEALS HIGH HCV SEROPREVALENCE IN PREGNANT WOMEN FROM NEW YORK STATE" by Linda M Styer of New York State Department of Health, Albany, NY, USA

ORAL ABSTRACT: GONE BUT NOT FORGOTTEN: HCV AFTER DIRECT-ACTING ANTIVIRAL THERAPY

"HEPATOCELLULAR CARCINOMA RISK AMONG PERSONS WITH HIV IN NORTH AMERICA, 1996-2015" by Jing Sun of Johns Hopkins University, Baltimore, MD, USA

ORAL ABSTRACT: GONE BUT NOT FORGOTTEN: HCV AFTER DIRECT-ACTING ANTIVIRAL THERAPY

"HIV/HCV VS HCV: PLASMA AND LIVER VIRAL DYNAMICS AND IP-10 LEVELS" by Ashwin Balagopal of Johns Hopkins University, Baltimore, MD, USA

ORAL ABSTRACT: GONE BUT NOT FORGOTTEN: HCV AFTER DIRECT-ACTING ANTIVIRAL THERAPY

"CLINICAL PREDICTORS OF LIVER FIBROSIS PRESENCE & PROGRESSION IN HIV-ASSOCIATED NAFLD" by Lindsay T Fourman of Massachusetts General Hospital, Boston, MA, USA

ORAL ABSTRACT: GONE BUT NOT FORGOTTEN: HCV AFTER DIRECT-ACTING ANTIVIRAL THERAPY

"QUESTIONS AND ANSWERS" by of

ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND CHILD HEALTH

"DOLUTEGRAVIR-CONTAINING ART DOES NOT REDUCE ETONOGESTREL IMPLANT CONCENTRATIONS" by Rena Patel of University of Washington, Seattle, WA, USA

ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND CHILD HEALTH

"SAFETY AND EFFICACY OF DTG VS EFV AND TDF VS TAF IN PREGNANCY: IMPAACT 2010 TRIAL" by Lameck Chinula of University of North Carolina Project-Malawi, Lilongwe, Malawi, Malawi

ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND CHILD HEALTH

"DIFFERENTIATED CARE FOR POSTPARTUM ART IN SOUTH AFRICAN WOMEN LIVING WITH HIV: AN RCT" by Jasantha Odayar of University of Cape Town, Cape Town, Western Cape, South Africa

ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND CHILD HEALTH

"POC EID VS CENTRAL LAB TESTING: RESULTS FROM A STEP-WEDGE RCT IN KENYA AND ZIMBABWE" by Emma Sacks of Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA

ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND CHILD HEALTH

"A RANDOMIZED TRIAL OF POINT-OF-CARE EARLY INFANT HIV DIAGNOSIS IN ZAMBIA" by Carla J. Chibwesha of University of North Carolina Chapel Hill, Chapel Hill, NC, USA

ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND CHILD HEALTH

"POPULATION-LEVEL HIV-FREE INFANT SURVIVAL IN THE SEARCH TRIAL" by Theodore Ruel of University of California, San Francisco, San Francisco, CA, USA

ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND CHILD HEALTH

"PREDICTORS OF THE PERSISTING VIRAL RESERVOIR IN VERY EARLY TREATED INFANTS" by Louise Kuhn of Columbia University, New York, NY, USA

ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND CHILD HEALTH

"LONG-TERM TREATMENT OUTCOMES: EARLY VERSUS DEFERRED ART IN CHILDREN LIVING WITH HIV" by Thanyawee Puthanakit of Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND CHILD HEALTH

"QUESTIONS AND ANSWERS" by of

ORAL ABSTRACT: TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HIV TESTING

"ANTIMICROBIAL PROPHYLAXIS AMONG AFRICAN ADULTS ON ART: RESULTS OF A RANDOMIZED TRIAL" by Randy George Mungwira of World Health Organization, Lilongwe, Malawi

ORAL ABSTRACT: TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HIV TESTING

"ISONIAZID TO PREVENT MTB INFECTION IN HIV-EXPOSED UNINFECTED INFANTS" by Sylvia LaCourse of University of Washington, Seattle, WA, USA

ORAL ABSTRACT: TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HIV TESTING

"PREDICTORS OF TUBERCULOSIS INFECTION IN MDR-TB HOUSEHOLD CONTACTS ≥15 YEARS OLD" by Soyeon Kim of Frontier Science Foundation, Brookline, MA, USA

ORAL ABSTRACT: TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HIV TESTING

"DIAGNOSTIC AND THERAPEUTIC CHALLENGES ARISE WITH EARLY HIV INFECTION ON PREP" by Michael J Peluso of University of California San Francisco, San Francisco, CA, USA

ORAL ABSTRACT: TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HIV TESTING

"A RANDOMIZED TRIAL OF INCENTIVES AND DEPOSIT CONTRACTS TO PROMOTE HIV RETESTING" by Gabriel Chamie of University of California, San Francisco, San Francisco, CA, USA

ORAL ABSTRACT: TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HIV TESTING

"COMMUNITY-BASED HIV TESTING IN URBAN KENYA: A STRATEGY TO REACH MEN AND YOUTH" by Hong-Ha M. Truong of University of California, San Francisco, San Francisco, CA, USA

ORAL ABSTRACT: TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HIV TESTING

"EFFECTIVENESS OF 3HP ANNUALLY VS ONCE FOR HIV-POSITIVE PEOPLE: THE WHIP3TB TRIAL" by Gavin Churchyard of Aurum Institute, Johannesburg, Gauteng, South Africa

ORAL ABSTRACT: TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HIV TESTING

"RIFAPENTINE PHARMACOKINETICS AND SAFETY IN PREGNANT WOMEN WITH AND WITHOUT HIV ON 3HP" by Jyoti S. Mathad of Weill Cornell Medicine, New York, USA, NY, USA

ORAL ABSTRACT: TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HIV TESTING

"QUESTIONS AND ANSWERS" by of

ORAL ABSTRACT: THE GOOD, THE BAD, AND THE UGLY: HIV INCIDENCE AND OUTCOMES IN SELECTED POPULATIONS

"NO HIV INCIDENCE INCREASE IN FIRST-TIME BLOOD DONORS WITH 12-MONTH DEFERRAL FOR MSM" by Eduard Grebe of Vitalant Research Institute, San Francisco, CA, USA

ORAL ABSTRACT: THE GOOD, THE BAD, AND THE UGLY: HIV INCIDENCE AND OUTCOMES IN SELECTED POPULATIONS

"EXPLAINING RACIAL DISPARITIES IN VIRAL SUPPRESSION AMONG MSM LIVING WITH HIV" by Justin Ryan Knox of Columbia University, New York, NY, USA

ORAL ABSTRACT: THE GOOD, THE BAD, AND THE UGLY: HIV INCIDENCE AND OUTCOMES IN SELECTED POPULATIONS

"EXPLOSIVE HIV AND HCV EPIDEMICS DRIVEN BY NETWORK VIREMIA AMONG PWID" by Sunil S. Solomon of Johns Hopkins University School of Medicine, BALTIMORE, MD, USA

ORAL ABSTRACT: THE GOOD, THE BAD, AND THE UGLY: HIV INCIDENCE AND OUTCOMES IN SELECTED POPULATIONS

"THE AGING OF HIV-1 INCIDENCE IN HYPERENDEMIC RURAL SOUTH AFRICA" by Adam N. Akullian of Institute for Disease Modeling, Bellevue, WA, USA

ORAL ABSTRACT: THE GOOD, THE BAD, AND THE UGLY: HIV INCIDENCE AND OUTCOMES IN SELECTED POPULATIONS

"HIGH HIV INCIDENCE IN YOUNG WOMEN IN THE BOTSWANA COMBINATION PREVENTION PROJECT" by Faith Ussery of Centers for Disease Control, Atlanta, GA, USA

ORAL ABSTRACT: THE GOOD, THE BAD, AND THE UGLY: HIV INCIDENCE AND OUTCOMES IN SELECTED POPULATIONS

"RAPIDLY DECLINING HIV INCIDENCE AMONG MEN AND WOMEN IN RAKAI, UGANDA" by Mary K Grabowski of Johns Hopkins School of Medicine, Baltimore, MD, USA

ORAL ABSTRACT: THE GOOD, THE BAD, AND THE UGLY: HIV INCIDENCE AND OUTCOMES IN SELECTED POPULATIONS

"INCREASED OVERALL LIFE EXPECTANCY BUT NOT COMORBIDITY-FREE YEARS FOR PEOPLE WITH HIV" by Julia L. Marcus of Harvard Medical School, Boston, MA, USA

ORAL ABSTRACT: THE GOOD, THE BAD, AND THE UGLY: HIV INCIDENCE AND OUTCOMES IN SELECTED POPULATIONS

"LOW-LEVEL VIREMIA DURING ART AND THE RISK OF DEATH, AIDS, AND SERIOUS NON-AIDS EVENTS" by Olof Elvstam of Lund University, Malmö, Sweden

ORAL ABSTRACT: THE GOOD, THE BAD, AND THE UGLY: HIV INCIDENCE AND OUTCOMES IN SELECTED POPULATIONS

"QUESTIONS AND ANSWERS" by of

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"SESSION INTRODUCTION" by Richard A. Koup of National Institutes of Health, Bethesda, MD, USA

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"THE RV144 VACCINE PRIMED IGG4 AND V1V2-ADCP RESPONSES IN HIV BREAKTHROUGH INFECTIONS" by Thembi Mdluli of US Military HIV Research Program, silver spring, MD, USA

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"PHASE I/IIA TRIAL OF HIV CLADE C DNA WITH MF59- OR AS01B-ADJUVANTED CLADE C PROTEIN" by Nigel Garrett of CAPRISA, Durban, South Africa

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"MUCOSAL T AND B CELL RESPONSES INDUCED BY ALVAC-HIV/AIDSVAX B/E LATE BOOST STRATEGIES" by Alexandra Schuetz of US Military HIV Research Program (MHRP), Bangkok, Thailand

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"ACUTE INFECTION B-CELL DETERMINANTS PREDICT DEVELOPMENT OF NEUTRALIZATION BREADTH" by Shelly J Krebs of Walter Reed Army Institute of Research, Silver Spring, MD, USA

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"SESSION INTRODUCTION" by Linos Vandekerckhove of Ghent University, Ghent, Belgium

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"PARALLEL HIV RNA, INTEGRATION SITE, AND PROVIRAL SEQUENCING IN SINGLE RESERVOIR CELLS" by Kevin Einkauf of Brigham and Women's Hospital, Cambridge, MA, USA

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"SINGLE-CELL ATLAS AND CLONAL EXPANSION DYNAMICS OF CD4+ T CELLS DURING HIV INFECTION" by Jack A Collora of Yale University, New Haven, CT, USA

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"TCR SEQUENCING REVEALS CLONAL EXPANSIONS OF INDUCIBLE RESERVOIRS IN SPECIFIC SUBSETS" by Pierre Gantner of Université de Montréal, MONTREAL, Québec, Canada

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"ONLY A FEW HIV-1 INTEGRATION SITES CONFER GROWTH ADVANTAGE TO INFECTED CELLS IN VIVO" by John M. Coffin of Tufts University, Boston, MA, USA

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"HIV DYNAMICS AND REPOPULATION OF RESERVOIRS IN THE HUMAN BODY" by Antoine Chaillon of University of California San Diego, La Jolla, CA, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"SESSION INTRODUCTION" by Ethel D. Weld of The Johns Hopkins University, Baltimore, MD, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"CABOTEGRAVIR AND RILPIVIRINE PK FOLLOWING LONG-ACTING HIV TREATMENT DISCONTINUATION" by Susan Ford of GlaxoSmithKline, RTP, NC, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"MK-8504 AND MK-8583 (TENOFOVIR PRODRUGS) SINGLE-DOSE PK AND ANTIVIRAL ACTIVITY IN HIV INFECTION" by Randolph P Matthews of Merck Research Laboratories, North Wales, PA, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"DOSE-RESPONSE RELATIONSHIP OF SUBCUTANEOUS LONG-ACTING HIV CAPSID INHIBITOR GS-6207" by Eric Daar of Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"ANTIRETROVIRAL & RIFAMPICIN COTREATMENT AFFECTS DMPA EXPOSURE: DOSING IMPLICATIONS" by Jose Francis of University of Cape Town, Cape Town, Western Cape, South Africa

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"SESSION INTRODUCTION" by Andrew D Kerkhoff of University of California, San Francisco, San Francisco, CA, USA

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"PREVALENCE OF TB SYMPTOMS, DIAGNOSIS, AND TREATMENT AMONG HIV PATIENTS NOT ON ART" by Alana T Brennan of Boston University School of Public Health, Boston, MA, USA

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"CHARACTERISATION OF SOUTH AFRICA’S XPERT MTB/RIF ULTRA 'TRACE' LABORATORY RESULTS" by Lesley Scott of University of the Witwatersrand, Johannesburg, Gauteng, South Africa

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"PROMISING COMBINED IMMUNOLOGICAL ASSAYS TO DIAGNOSE CHILDHOOD TUBERCULOSIS" by Jean-Pierre Molès of Inserm, Montpellier, France

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"DIAGNOSTIC PERFORMANCE OF A SEMIQUANTITATIVE POINT-OF-CARE ASSAY FOR CRYPTOCOCCOSIS" by Tadeo Kandole Kiiza of Makerere University, Kampala, kampala, Uganda

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"SUPERIOR ACCURACY OF THE MP1P ANTIGEN ASSAY OVER CULTURES IN DIAGNOSING TALAROMYCOSIS" by Ly Trieu Vo of Ho Chi Minh City Medicine and Pharmacy University, Ho Chi Minh City, Viet Nam

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"SESSION INTRODUCTION" by Caroline Mitchell of Harvard Medical School/Massachusetts General Hospital, Boston, MA, USA

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"GENITAL SECRETIONS FROM WOMEN WITH BACTERIAL VAGINOSIS ENHANCE HIV INFECTION EX VIVO" by Marla J Keller of Albert Einstein College of Medicine, Bronx, NY, USA

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"DMPA-IM DRIVES CERVICAL TH17 HIV TARGET-CELL ACCUMULATION IN WOMEN IN ECHO TRIAL" by Rubina Bunjun of University of Cape Town, Cape Town, South Africa

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"INCREASED GENITAL INFLAMMATION IN WOMEN RANDOMIZED TO COPPER IUD IN THE ECHO TRIAL" by Tanko F Ramla of University of Cape Town, Cape Town, South Africa

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"A COMBINED ESTROGEN/PROGESTIN VAGINAL RING IMPROVES VAGINAL MICROBIAL COMMUNITIES" by Nicole H. Tobin of University of California, Los Angeles, Los Angeles, CA, USA

SYMPOSIUM: DOUBLE-EDGED SWORD OF INFLAMMATION

"USING SYSTEMS BIOLOGY TO UNDERSTAND THE MECHANISMS OF VACCINE EFFICACY" by Bali Pulendran of Stanford University, Stanford, USA

SYMPOSIUM: DOUBLE-EDGED SWORD OF INFLAMMATION

"DECODING THE TRANSCRIPTIONAL INFLAMMATORY CASCADES THAT MAINTAIN HIV RESERVOIR" by Susan Pereira Ribeiro of Case Western Reserve University, Cleveland, OH, USA

SYMPOSIUM: DOUBLE-EDGED SWORD OF INFLAMMATION

"DISSECTING THE DRIVERS OF CHRONIC INFLAMMATION" by Krystelle Nganou of University Hospital Erlangen, Erlangen, Germany

SYMPOSIUM: DOUBLE-EDGED SWORD OF INFLAMMATION

"DEFINING TREATABLE PATHWAYS IN INFLAMMAGING: IS IT NICE TO FOOL WITH MOTHER NATURE?" by Michael M Lederman of Case Western Reserve University, Cleveland, OH, USA

SYMPOSIUM: ANTIRETROVIRAL THERAPY: THE LONG GAME

"NOVEL ANTIRETROVIRAL AGENTS: TRANSFORMING THE CARE OF PEOPLE WITH HIV" by Rajesh T Gandhi of Massachusetts General Hospital, Boston, MA, USA

SYMPOSIUM: ANTIRETROVIRAL THERAPY: THE LONG GAME

"PEDIATRIC AND ADOLESCENT ART: A ROAD LESS TRAVELLED" by Carolyn Bolton Moore of University of Alabama at Birmingham, Lusaka, Zambia

SYMPOSIUM: ANTIRETROVIRAL THERAPY: THE LONG GAME

"METABOLIC COMPLICATIONS OF HIV AND ITS THERAPIES" by Jordan E Lake of University of Texas Health Science Center Houston, Houston, TX, USA

SYMPOSIUM: ANTIRETROVIRAL THERAPY: THE LONG GAME

"GETTING IT RIGHT: PRACTICAL APPROACHES TO ADHERENCE WITH MODERN ARVS" by Jose R Castillo-Mancilla of University of Colorado Denver, Aurora, CO, USA

SYMPOSIUM: HEPATITIS C: PARALLELS, PITFALLS, AND PROMISE

"GLOBAL EPIDEMIOLOGY OF HEPATITIS C" by Yvan J-F Hutin of World Health Organization, Cairo, Egypt

SYMPOSIUM: HEPATITIS C: PARALLELS, PITFALLS, AND PROMISE

"MODELING AND EXAMPLES OF HCV ELIMINATION: POSSIBILITIES, ACHIEVEMENTS, AND NEXT STEPS" by Natasha Martin of University of California San Diego, San Diego, CA, USA

SYMPOSIUM: HEPATITIS C: PARALLELS, PITFALLS, AND PROMISE

"VERTICAL HEPATITIS C TRANSMISSION: DÉJÀ VU ALL OVER AGAIN?" by Ali Judd of University College London, London, United Kingdom

SYMPOSIUM: HEPATITIS C: PARALLELS, PITFALLS, AND PROMISE

"HEPATITIS C TREATMENT ON A SHOESTRING" by Isabelle Andrieux-Meyer of Drugs for Neglected Diseases Initiative, Geneva, Switzerland